Doing some CME and just
read this. Study had 3 arms: durvalumab, durvalumab + tremelimumsb, and placebo. The rest of the article then only discussed durvalumab vs placebo and appears to ignore the 2nd arm. What am I missing?
1
Doing some CME and just
read this. Study had 3 arms: durvalumab, durvalumab + tremelimumsb, and placebo. The rest of the article then only discussed durvalumab vs placebo and appears to ignore the 2nd arm. What am I missing?
1